泊洛沙姆稀释法:琼脂稀释法的按需替代方案
研究评估用泊洛沙姆407替代琼脂作为凝固剂进行药敏试验。对磷霉素测试中,泊洛沙姆稀释法与参考琼脂稀释法在大肠埃希菌中分类一致性和基本一致性分别为100%和87%(n=31),且无重大误差;该方法能减少跳孔并抑制变形杆菌迁徙。结论认为泊洛沙姆稀释法可作为临床实验室按需替代方法用于革兰阴性菌磷霉素测试。
要点
- 泊洛沙姆407溶液冷藏为液体,加热凝固,便于配制药敏板。
- 对大肠埃希菌磷霉素测试,分类一致性100%,基本一致性87%。
- 泊洛沙姆稀释法减少跳孔六倍(P<0.0001)并抑制变形杆菌迁徙。
核心结论
- 泊洛沙姆稀释法与琼脂稀释法在实际性能上基本等效,可作为临床实验室按需替代方法用于革兰阴性菌磷霉素测试。
- 有必要更广泛地探索泊洛沙姆稀释法的应用价值。
研究设计与样本
- 本研究为方法学比较研究,评估泊洛沙姆407替代琼脂作为凝固剂进行药敏试验。
- 磷霉素测试中,大肠埃希菌n=31,其他肠杆菌目(除克雷伯菌属)n=17,铜绿假单胞菌n=10。
主要发现
- 大肠埃希菌:分类一致性100%,基本一致性87%(n=31)。
- 其他肠杆菌目(除克雷伯菌属):分类一致性和基本一致性均为82%(n=17)。
- 铜绿假单胞菌:分类一致性60%,基本一致性100%(n=10),较低分类一致性反映大量菌株MIC接近分类折点。
- 无极重大误差,重大误差仅见于克雷伯菌属。
- 泊洛沙姆稀释法使大肠埃希菌跳孔减少六倍(P<0.0001),并抑制变形杆菌迁徙。
临床怎么用
- 泊洛沙姆稀释法可在临床实验室按需进行磷霉素对革兰阴性菌的MIC测试,无需特殊设备。
- 该方法提供参考质量的MIC数据,可支持及时治疗决策。
局限性
- 琼脂稀释法为不完美的金标准。
- 研究样本量有限,需更广泛探索泊洛沙姆稀释法的实用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Agar dilution is a reference susceptibility testing method uniquely or preferentially recommended for certain antimicrobials. However, the effort required to pour individual agar plates spanning a doubling dilution range precludes its practical implementation in hospital clinical laboratories. Here, we describe an on-demand replacement for agar dilution, specifically substituting Poloxamer 407 (also known as Pluronic F-127) for Bacto agar as the solidifying agent. Notably, 20% Poloxamer 407 solutions (e.g., with Mueller-Hinton broth) remain liquid at refrigerated temperatures but solidify upon warming, enabling facile setup of poloxamer dilution testing in Petri dish or microwell format. For fosfomycin susceptibility testing, poloxamer dilution and reference agar dilution showed excellent categorical agreement (CA) and essential agreement (EA) for Escherichia coli (100% and 87%, respectively, n = 31). For other Enterobacterales, excluding Klebsiella spp., CA and EA were both 82% (n = 17, respectively). For Pseudomonas aeruginosa, CA and EA were 60% and 100% (n = 10), respectively, with the lower CA reflecting the large number of strains tested with minimal inhibitory concentrations near categorical breakpoints. There were no very major errors, while major errors were only observed for Klebsiella spp. Additionally, poloxamer dilution substantially reduced the number of skipped dilutions sixfold for E. coli (P < 0.0001) and inhibited swarming of Proteus spp. We conclude that poloxamer dilution and agar dilution, an imperfect gold standard, have essentially equivalent practical performance and that poloxamer dilution can therefore serve as an on-demand alternative testing methodology in clinical laboratories for fosfomycin testing of gram-negative pathogens. A broader exploration of poloxamer dilution's utility is thus warranted. IMPORTANCE: Accurate antibiotic susceptibility testing is essential for guiding treatment of bacterial infections. For the antibiotic fosfomycin, used to treat Escherichia coli urinary tract infections, the most reliable testing method requires solid media prepared by hand for each antibiotic concentration, which is too time-consuming for most clinical laboratories to perform. Our study shows that replacing agar with an alternative temperature-sensitive gelling agent called poloxamer enables laboratories to prepare solid test plates rapidly without special equipment. This approach, which is essentially identical to traditional agar dilution, provides a practical means for performing reference-quality minimal inhibitory concentration (MIC) testing near the point of patient care, as demonstrated for fosfomycin, for which current FDA-cleared methods do not provide MIC data. This strategy may also be applicable to other drugs for which agar dilution is the preferred testing method, supporting expedited testing to inform treatment decisions for bacterial infections.
引用
- Uy MTJ, Kirmaier A, Rudtner LM, et al. Poloxamer dilution as an on-demand alternative to agar dilution-based antimicrobial susceptibility testing. J Clin Microbiol. 2026. PMID: 41784364. doi:10.1128/jcm.01822-25
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。